The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Kirsten K AhringFrederik Dagnæs-HansenAnnemarie BrüelMette ChristensenErik JensenThomas G JensenMogens JohannsenKaren S JohansenAllan M LundJesper G MadsenKaren Brøndum-NielsenMichael PedersenLambert K SørensenMads KjolbyLisbeth B MøllerPublished in: PloS one (2022)
CGMP can be a relevant supplement for the treatment of PKU.